Reconstitution of cytochrome b-560 (QPs1) of bovine heart mitochondrial succinate–ubiquinone reductase1This work was supported in part by a grant from the NIH (GM30721).1  by Lee, Gyesoon Yoon et al.
 .Biochimica et Biophysica Acta 1363 1998 35–46
 /Reconstitution of cytochrome b-560 QPs1 of bovine heart
mitochondrial succinate–ubiquinone reductase 1
Gyesoon Yoon Lee, Jian Zhu, Linda Yu ), Chang-An Yu
Department of Biochemistry and Molecular Biology, Oklahoma State Uni˝ersity, Stillwater, OK 74078, USA
Received 16 June 1997; revised 11 September 1997; accepted 15 September 1997
Abstract
The QPs1 subunit of bovine heart mitochondrial succinate–ubiquinone reductase was overexpressed in Escherichia coli
 .DH5a cells as a glutathione S-transferase fusion protein GST–QPs1 using the expression vector, pGEXrQPs1. The yield
of soluble active recombinant GST–QPs1 fusion protein depends on the IPTG concentration, induction growth time,
temperature, and medium. Maximum yield of recombinant fusion protein was obtained from cells harvested 3 h postinduc-
tion of growth with 0.5 mM IPTG at 278C in an enriched medium containing betaine and sorbitol. QPs1 is released from the
fusion protein by proteolytic cleavage with thrombin. Isolated recombinant QPs1 shows one protein band in SDS-polyacryl-
amide gel electrophoresis corresponding to subunit III of mitochondrial succinate–ubiquinone reductase. However, partial
N-terminal amino acid sequence analysis of recombinant QPs1 shows two extra amino acid residues, glycine and serine, at
the N-terminus of mature QPs1, resulting from the recombinant manipulation. When isolated recombinant QPs1 is dispersed
in 0.01% dodecyl maltoside, it is in a highly aggregated form with an apparent molecular mass of over 1 million.
Recombinant GST–QPs1 contains little cytochrome b-560 heme. However, addition of hemin chloride restores the spectral
characteristics of cytochrome b-560. Cytochrome b-560 restoration varies with the amount of hemin used. Maximum
reconstitution is obtained when the molar ratio of heme to fusion protein used in the system is 0.6. Reconstituted
cytochrome b-560 shows a EPR signal at gs2.91 which corresponds to one of the EPR signals of cytochrome b-560 in a
QPs preparation. When GST–QPs1 with reconstituted cytochrome b-560 is treated with thrombin to cleave GST from
QPs1, no change in the absorption and EPR characteristics of cytochrome b-560 is observed, indicating that the bis-histidine
ligands of reconstituted cytochrome b-560 are provided by QPs1. q 1998 Elsevier Science B.V.
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1. Introduction
Bovine heart mitochondrial succinate–ubiquinone
reductase, also known as Complex II, which cat-
alyzes electron transfer from succinate to ubiquinone
 . w xQ , has been isolated and characterized 1–3 . The
reductase is composed of two parts: soluble succinate
dehydrogenase and a membrane anchoring protein
fraction. Purified reductase shows five protein sub-
units in a high resolution sodium dodecylsulfate-
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 .polyacrylamide gel electrophoretic SDS-PAGE sys-
tem with apparent molecular weights of 70, 27, 15,
w x13, and 11 kDa 4 . The two largest subunits are
succinate dehydrogenase and the three smaller ones
comprise the membrane anchoring protein fraction.
The isolated complex contains six prosthetic groups:
one FAD, three iron–sulfur clusters 2Fe–2S, 3Fe–
.4S, and 4Fe–4S , cytochrome b-560, and Q. The
 .FAD is covalently bound to the 70 kDa subunit Fp
and all three iron–sulfur clusters are in the 27 kDa
 . w xsubunit Ip of succinate dehydrogenase 5,6 . Cy-
tochrome b-560 and Q are found in the membrane
w xanchoring protein fraction 7 . While studies of succi-
nate dehydrogenase have been extensive and a wealth
w xof information has been obtained 5,6 , knowledge of
the membrane anchoring protein fraction is relatively
w xlimited 8 .
The membrane anchoring protein fraction has been
isolated in several laboratories under different names,
w x w xsuch as CII 9 , cytochrome b-560 fraction 10 , or3, 4
w xQPs 11 . QPs provides membrane anchoring for
succinate dehydrogenase and is responsible for the
Q-binding in succinate–ubiquinone reductase. The
ubisemiquinone radicals, which do not show power
saturation, even at 200 mW, are detected in intact and
reconstituted succinate–ubiquinone reductases in the
w xpresence of exogenous Q 12 . When quinone deriva-
tives are used as the electron acceptor for succinate–
ubiquinone reductase, a 5 carbon side chain is re-
w xquired for maximum activity 13 and the methyl
group at the 5-position is less important than are the
w xmethoxy groups at the 2- and 3-positions 14 . Re-
placing the 5-methyl group with hydrogen causes a
slight increase in activity. However, replacing one or
both of the 2- and 3-methoxy groups with a methyl
completely abolishes electron-acceptor activity.
When succinate–ubiquinone reductase is subjected
w3 xto photoaffinity labeling with an H azido-Q deriva-
tive, most of the radioactivity was found in the QPs1
subunit, indicating that QPs1 is involved in Q-bind-
w xing 4 . The Q-binding domain in QPs1, using a
structure for QPs1 based on the deduced amino acid
w xsequence 15,16 , is located in the stretch connecting
transmembrane helices 2 and 3, which extrudes from
the surface of the M side of the mitochondrial inner
w xmembrane 4 .
In addition to participating in Q-binding, QPs1 is
believed to be cytochrome b-560. The involvement
of cytochrome b-560 in catalysis by succinate–
ubiquinone reductase is controversial. The presence
of substoichiometric amounts of cytochrome b-560,
with respect to FAD, in isolated beef succinate–cyto-
chrome c and succinate–ubiquinone reductases, to-
gether with its non-reducibility by succinate has led
some investigators to rule out a catalytic function for
cytochrome b-560. On the other hand, it has been
proposed that cytochrome b-560 functions as a medi-
ator between low potential F1rFP and QrQP cou-
w xples in a dual pathway model 17 of electron flow
through cardiac Complex II. Despite its uncertain
catalytic role, cytochrome b-560 is involved in the
binding of succinate dehydrogenase to QPs as indi-
cated by the restoration of its absorption properties,
redox potential, and EPR characteristics, upon recon-
stitution of succinate–ubiquinone reductase from QPs
w xand succinate dehydrogenase 7 .
The ligands of cytochrome b-560 in E. coli and
beef succinate–ubiquinone reductases have recently
w xbeen identified as bis-histidine 18,19 . H42 and H98
of QPs1 are thought to be involved in heme ligation
w xof cytochrome b-560 in the beef enzyme 15 because
these two histidines are conserved in sdh C peptides
of E. coli and Bacillus subtilis and are located on the
matrix side of the membrane. However, the recent
w xreport of Nakamura et al. 20 , using a gene deletion
approach, indicates that both sdhC and sdhD pep-
tides of the E. coli enzyme are required for heme
ligation of cytochrome b . Precise localization of556
these bis-histidine ligands will facilitate our under-
standing of electron transfer in this segment of the
mitochondrial respiratory chain.
To better understand the structure function rela-
tionship of QPs1 requires knowledge of the amino
acid residues responsible for Q-binding, succinate
dehydrogenase docking, and ligation of cytochrome
b-560. This can be obtained by using expressed
mutated QPs1 for in vitro reconstitution. Therefore
toward this end, we have developed a method to
over-express QPs1 in E. coli as a glutathione S-trans-
 .ferase GST fusion protein, using the pGEX expres-
w xsion vector system 21 . We have used this system,
which allows one-step affinity purification of the
recombinant fusion protein with glutathione–agarose
gel, to over-express functionally active subunit IV of
w xthe R. sphaeroides cytochrome bc complex 22 and1
the QPc-9.5 kDa of beef ubiquinol–cytochrome c
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w xreductase 23 . Herein we report construction of a
QPs1 expression vector, pGEXrQPs1, conditions for
high expression of the active soluble form of GST–
QPs1 in E. coli DH5a , and isolation and characteri-
zation of pure recombinant QPs1. Reconstitution of
recombinant QPs1 with heme to form cytochrome
b-560 and the properties of reconstituted cytochrome
b-560 are also discussed.
2. Experimental procedures
2.1. Materials
Restriction endonucleases, T4 DNA ligase, T4
DNA polymerase and T4 polynucleotide kinase were
obtained from either Promega Corporation or
 .Bethesda Research Laboratories. DNase I Type IV ,
RNase A, isopropyl-b-D-thiogalactopyranoside
 .IPTG , gelatin, ampicillin, tetracycline, D-amino-
levulinic acid, ferrous sulfate, hemin chloride, sor-
 .bitol, betaine, glutathione reduced form , glu-
tathione–agarose beads, thrombin, leupeptin, 2,6-di-
 .chlorophenol indophenol DCPIP and phenylmethyl-
 .sulfonylfloride PMSF were from Sigma. Nitrocellu-
lose membrane was from MSI. Agarose, acrylamide,
bis-acrylamide, HRP color development reagents
4CN, and protein A horseradish peroxidase conjugate
were from Bio-Rad. LB agar, LB broth base, Select
Peptone-140, and Select Yeast Extract were from
GIBCO BRL. Oligonucleotides were synthesized by
the DNArProtein Core Facility at Oklahoma State
University. Antibodies against QPs1 were generated
in rabbits and purified by the method previously
w xreported 15 . Other chemicals were obtained com-
mercially in the highest purity available.
2.2. Bacterial strains and plasmids
E. coli JM109 recA1, endA1, gyrA96, thi-,
 y y. y hsdR17 r , m , supE44, relA1, l , D lac–k k
. w X q x4proAB , F , traD36, proAB lacI Z DM15 was
 .  .used as host for pGEM-3Zf q Promega , pSelect
 .  .Promega , and pGEX-2TH Pharmacia plasmids. E.
 ycoli DH5a F , f80d, lacZDM15, endA1, recA1,
 y q. yhsdR17 r , m , supE44, thi-1, d , gyrA96,k k
 . 4D lacZYA-argF , U169 was used as host for pGEX-
2THrQPs1. E. coli strains were grown in LB medium
w x  .24 . When necessary, ampicillin 100 mgrml or
 .tetracycline 15mgrml were added.
2.3. DNA manipulation and DNA sequencing
Restriction enzyme digestion, large-scale isolation
and minipreparation of plasmid DNA, were per-
w xformed according to reported methods 24 . Site-di-
rected mutagenesis was performed using the Altered
Site in vitro Mutagenesis system from Promega. DNA
sequencing was performed by the DNArProtein Core
Facility at Oklahoma State University.
2.4. Isolation of recombinant GST–QPs1 fusion pro-
tein
2.4.1. From soluble cell-free extract
Recombinant GST–QPs1 fusion protein was iso-
lated from E. coli DH5arpGEXrQPs1 cell extracts
w xessentially as described previously 23 . 250 ml of an
overnight grown E. coli DH5arpGEXrQPs1 cell
culture was used to inoculate 12 l of enriched medium
containing 2.5 mM betaine, 440 mM sorbitol, and
100 mgrml ampicillin, and incubated at 378C with
vigorous shaking until the OD reached 0.7. The660 nm
culture was cooled to 278C and IPTG was added to a
final concentration of 0.5 mM to induce the synthesis
of the GST–QPs1 fusion protein. Cells were grown
at 278C for 3 h before they were harvested by cen-
trifugation at 8000=g for 15 min. Forty three grams
of cell paste were obtained. Freshly harvested cells
were suspended in 80 ml of 20 mM sodium phosphate
 .buffer, pH 7.3, containing 150 mM NaCl PBS and
broken with a SLM-Aminco French pressure cell at
 .1000 p.s.i. PMSF 100 mM in absolute alcohol was
added to the broken cell suspension in several small
portions during the pressing process to a final con-
centration of 1 mM, to inhibit protease activity. Tri-
ton X-100 was then added to a final concentration of
 .1% wrv . This mixture was stirred for 1 h at 08C
and centrifuged at 30 000=g for 20 min. The super-
natant obtained was mixed with an equal volume of
glutathione–agarose gel equilibrated with PBS. The
precipitate, which contains inclusion body QPs1, was
saved for the isolation of QPs1 by urea solubilization
as described in the next section. The gel mixture was
gently shaken for 2 h at 08C and packed into a
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2.5=13 cm column. After the column was washed
with 800 ml of 50 mM Tris–Cl buffer, pH 7.5, fol-
lowed with 100 ml of 50 mM Tris–HCl, pH 8.0,
containing 0.1 mM glutathione and 0.25 M sucrose,
the GST–QPs1 fusion protein was eluted with 50 mM
Tris–HCl, pH 8.0, containing 5 mM glutathione and
0.25 M sucrose and dialyzed against 50 mM Tris–Cl,
pH 8.0, containing 0.25 M sucrose, overnight, with
two changes of buffer. The dialyzed preparation was
concentrated to 10 mgrml with Centricon-10, mixed
with glycerol to a final concentration of 10%, and
frozen at y808C until use.
2.4.2. From Inclusion Body Precipitate
The precipitate was suspended in an equal volume
of 8 M urea in 50 mM Tris–Cl buffer, pH 8.0 and
stirred at room temperature for 30 min. After the
mixture was centrifuged at 30 000=g for 30 min, the
supernatant was dialyzed against 50 mM Tris–Cl, pH
8.0, overnight, with two changes of buffer, to remove
urea. The dialyzed sample was centrifuged at 30 000
=g for 30 min to remove precipitates. Fusion protein
was isolated from the clear supernatant using the
procedure described above for the soluble cell-free
extract.
2.4.3. Enzyme preparations and assays
w x w xSuccinate dehydrogenase 25 and QPs 7 were
prepared and assayed as previously reported. The
reconstitutive activity of QPs1 was assayed by its
ability to form succinate–ubiquinone reductase with
succinate dehydrogenase. Succinate–ubiquinone re-
ductase was assayed for its ability to catalyze the
Q-mediated DCPIP reduction by succinate. One ml
assay mixture contains 100 mmoles of sodiumrpotas-
sium phosphate buffer, pH 7.4, 50 nmoles of DCPIP,
20 mmoles of succinate, 10 nmoles of EDTA,
16 nmoles of Q and 0.1 mg of Triton X-100. The2
reduction of DCPIP was followed by an absorption
decrease at 600 nm using a millimolar extinction
coefficient of 21 cmy1.
Absorption spectra and spectrophotometric activity
assays were performed at room temperature in a
Shimadzu UV-2101PC spectrometer. Protein concen-
w xtration was determined by the Lowry method 26
using bovine serum albumin as standard. The heme
content was determined from the reduced pyridine
hemochromogen spectra using a millimolar extinction
coefficient of 34.6 for the absorbance at 557 nm
w xminus 600 nm 27 . Analytical SDS-PAGE was per-
formed in a Bio-Rad Mini-Protein dual slab cell
w xusing the gel system of Schagger et al. 28 , with¨
w xmodifications 4 . Western blots were performed as
w xpreviously described 23 . The EPR measurements
were made with a Bruker ER-200D equipped with an
Air Product Heli-Tran System. EPR settings and
temperatures are shown in the figure legends.
3. Results and discussion
3.1. Construction of the expression ˝ector for QPs1
( )pGEXrQPs1
Fig. 1 summarizes the protocol used for construc-
tion of the QPs1 expression vector, pGEXrQPs1.
The QPs1 gene was in-frame fused into the glu-
 .tathione S-transferase GST gene in pGEX-2TH
plasmid by generating a BamHI–HindIII fragment
encoding mature QPs1 and subsequently ligating it
into the BamHI and HindIII sites of the pGEX-2TH
plasmid. The 432 bp BamHI–HindIII fragment en-
coding mature QPs1 was obtained by first eliminating
 .the internal BamHI recognition sequence GGATCC ,
located at 304 bp down stream from the N-terminus
 .coding sequence TTG and 110 bp upstream from
 .the stop codon TGA , followed by creating a BamHI
site immediately before the N-terminus coding se-
 .quence and a HindIII site AAGCTT 7 bp down
stream from the stop codon. These constructions were
achieved by site-directed mutagenesis techniques.
To eliminate the internal BamHI site in QPs1
sequence, a 1.7 kbp SacI fragment from pGEMrQPs1
w x15 was cloned into the SacI site of pSelect-1 plas-
mid to generate pSelect rQPs1 for the use as aamp-
template in the mutagenesis reaction. The mutant
oligonucleotide, CTGGAATGGGATTCGA -
CACTTGAT, along with an ampicillin repair oligo-
nucleotide were included in the mutagenesis system.
Although this construction eliminates the BamHI site
from the QPs1 sequence, the resulting plasmid,
pSelect r QPs1 , encodes the identical QPs1amp D BamHI
sequence as that of intact QPs1.
To create a BamHI site immediately upstream
from the N-terminus coding sequence and a HindIII
site 7 bp down stream from the stop codon of QPs1
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Fig. 1. Construction of the QPs1 expression vector, pGEXrQPs1.
sequence, a 1.7 kb SacI fragment from pSelect ramp
QPs1 was cloned into the SacI site of pSelect-1D BamHI
plasmid to generate pSelect srQPs1 for useamp D BamHI
as a template. The two mutant oligonucleotides,
ATCAGAAATGCTGGATCCTTGGGAACCACA
 .BamHI recognition sequence , and AAGAGCTGA-
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AGCTTCCCAGTGTCA HindIII recognition se-
.quence , along with an ampicillin repair oligonucleo-
tide were included in the mutagenesis system to
generate pSelect r QPs1 .amp BD BH
A 432 bp BamHI–HindIII fragment from
pSelect r QPs1 was cloned into BamHI andamp BD BH
HindIII sites of pGEX-2TH to generate pGEXrQPs1
expression plasmid.
3.2. Effect of IPTG concentration, induction tempera-
ture, medium, and length on generation of soluble
recombinant fusion protein in E. coli DH5a
When the pGEXrQPs1 plasmid was transformed
into E. coli JM109, DH5a , or KS1000 cells, the
transformed DH5a cells required 2.5 h to reach the
midpoint of their logarithmic growth phase while
JM109 and KS1000 required 3.5 h. Furthermore, when
cells were harvested after three hours of IPTG induc-
tion growth at 378C, the amounts of GST–QPs1
fusion protein produced by these E. coli strains were
in the decreasing order of DH5a) JM109)
KS1000. Therefore, DH5a cells were used as the
host for expression of QPs1.
Production of recombinant GST–QPs1 fusion pro-
tein was found to be IPTG concentration and induc-
 .tion growth time dependent data not shown . The
yield increased as the IPTG concentration and induc-
tion growth time were increased, reaching a maxi-
mum when cells were harvested 3 h after 0.5 mM
IPTG growth induction. When cells were grown for
more than 3 h, the total yield decreased and degrada-
tive product increased, as determined by Western
Blotting using anti-QPs1 antibodies.
The production of recombinant GST–QPs1 fusion
protein by E. coli DH5a rpGEXrQPs1 in LB
medium at 378C is high; it accounts for about 8% of
 .the total cellular protein see Table 1 . However,
when the cells were broken by sonication in the
presence of 1% Triton X-100, only 5% of the fusion
protein produced was recovered in the crude extract
 .see Table 1 , indicating that the majority of recombi-
nant fusion protein was in insoluble aggregates in-
.clusion bodies . The insolubility of recombinant
GST–QPs1 limits the usefulness of the one-step pu-
rification scheme of the pGEX vector system. Only
when the recombinant protein is soluble or detergent
.soluble and possesses a properly folded GST-active
site, the binding of fusion protein to glutathione–
agarose is possible. There are two ways to obtain
active soluble recombinant fusion protein: one is to
change the cellular environment to make cells pro-
duce active soluble recombinant protein; the other is
to develop methods for converting insoluble dena-
tured recombinant GST–QPs1 fusion protein to a
soluble active form.
It is known that cellular environments are affected
by growth media, induction temperature, and length
of induction. Table 1 compares the soluble yield of
GST–QPs1 fusion protein from cells grown under
 .  .seven conditions: i LB broth medium at 378C; ii
 .LB broth medium at 278C; iii LB broth medium
containing 2.5 mM betaine and 440 mM sorbitol at
Table 1
The yield of recombinant GST–QPs1 fusion protein in the soluble and inclusion body fractions of E. coli DH5arpGEX-QPs1 cells
grown under different conditions
aGrowth medium Temperature Length of % Yield of GST–QPs1
8C induction growth
Total Soluble Inclusion bodyh
LB 37 3 8.1 0.4 7.7
LB 27 3 4.4 1.1 3.3
LBqbetaineqsorbitol 27 3 8.3 2.6 5.7
Enriched 27 3 9.4 1.4 8.0
Enrichedqbetaine 27 3 9.4 2.3 7.1
Enrichedqsorbitol 27 3 9.4 2.3 7.2
Enrichedqbetaineqsorbitol 27 3 10.2 4.2 6.0
a % yield of recombinant GST–QPs1 fusion protein was calculated by comparing the color density at the M s41 kDa molecular weightr
protein band with the total intensities of cellular protein bands in SDS-PAGE.
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 . 278C; iv enriched medium 2% Select peptone-140,
0.2% Na HPO , 0.1% KH PO , 0.8% NaCl, 1.5%2 4 2 4
.  .Select yeast extract, and 0.2% glucose at 278C; v
enriched medium containing 2.5 mM betaine at 278C;
 .vi enriched medium containing 440 mM sorbitol at
 .278C; and vii enriched medium containing 2.5 mM
betaine and 440 mM sorbitol at 278C.
Although induction at 278C in LB medium Table
.1 improved the soluble yield over induction at 378C
by 3-fold, the soluble recombinant GST–QPs1 is
only 1% of the total cellular protein. The total amount
of recombinant GST–QP1 fusion protein produced
by cells induced at 278C was only 55% that produced
 .by cells induced at 378C see Table 1 . Increased
yield of soluble recombinant polypeptide in E. coli at
a low growth temperature has been reported
w x23,29,30 .
To further improve the soluble yield, a method
using osmotic stress to facilitate the uptake of the
w x‘‘compatible solute’’ glycyl betaine was adopted 31
in conjunction with the low growth temperature.
When E. coli DH5arpGEXrQPs1 cells were grown
at 278C in LB medium containing 2.5 mM betaine
and 440 mM sorbitol, the total GST–QPs1 protein
 .produced was double 8.3% that produced without
 .betaine and sorbitol 4.4% with about 31% in the
 .soluble form Table 1 . Thus at low temperature,
inclusion of betaine and sorbitol causes increased
production of soluble GST–QPs1 and inclusion body
fusion protein. Although the reason for the increase is
w xunknown, it has been suggested 32 that increased
internal concentrations of compatible osmolytes, such
as betaine, cause a thermodynamically unfavorable
‘‘preferential hydration’’ which minimizes solvent–
protein contact and stabilizes protein structure.
The yield of the soluble form of a recombinant
protein can be increased in E. coli by using an
w xenriched medium 33 . Thus a peptone–phosphate
enriched medium 2% Select peptone-140, 0.2% %
Na HPO , 0.1% KH PO , 0.8% NaCl, 1.5% Select2 4 2 4
.yeast extract, and 0.2% glucose , in the presence of
betaine, or sorbitol, or both, was used for induction
growth of E. coli DH5arpGEXrQPs1 cells at 278C.
Results are presented in Table 1. It will be noted that
addition of both 2.5 mM betaine and 400 mM sorbitol
to enriched medium resulted in highest yield of total
 .  .10.2% and soluble 41% of total GST–QPs1 re-
combinant protein. Therefore, induction growth using
peptone–phosphate medium containing 2.5 mM be-
taine and 440 mM sorbitol at 278C for 3 h was opti-
mal for the production of soluble recombinant GST–
QPs1 fusion protein.
It should be mentioned that our routine cell extract
procedure included treatment with 1% Triton X-100.
If this treatment was omitted, the yield of soluble
recombinant GST–QP1 fusion protein from cells
grown in enriched medium containing betaine and
sorbitol decreased 15%. This suggests that some
GST–QPs1 fusion protein is either in a membrane
fraction or an inclusion body aggregate that can be
solubilized by Triton X-100 while maintaining the
GST-active site recognizable by glutathione–agarose
gel.
3.3. Reco˝ery of the recombinant GST–QPs1 fusion
protein from inclusion body precipitates
Despite the increased yield of soluble active GST–
 .QPs1 fusion protein Table 1 , about 60% of the
fusion protein remains in inclusion body complexes.
Recovery of the active soluble GST–QPs1 fusion
protein from inclusion precipitates was attempted in
order to increase the yields. Although recovery of
active recombinant protein from inclusion bodies has
been regarded as a formidable task, some successes
w xhave been reported 29,34,35 . In these cases, recom-
binant protein aggregates were solubilized with a
high concentration of urea, or other chaotropic
reagents, and dialyzed to allow proper refolding of
the protein. When the urea-dialysis method was
adopted, only 8.5% of the recombinant GST–QPs1
protein in inclusion bodies was recovered in the
soluble form. This low recovery results from re-pre-
cipitation of the urea-solubilized fusion protein dur-
ing dialysis and not from ineffective solubilization
from the inclusion body precipitates. More than 85%
of the recombinant fusion protein in inclusion precip-
itates is solubilized in 5 M urea, but about 90% of the
urea-solubilized protein precipitates upon removal of
urea. Inclusion of 0.2% sodium cholate in the dialysis
buffer slightly increases the yield of soluble GST–
 .QPs1 fusion protein 12% after dialysis. About 60%
of the soluble GST–QPs1 obtained from the inclu-
sion body complex by urea-dialysis is recovered from
the glutathione–agarose gel. Thus, only about 5% of
the recombinant GST–QPs1 in the inclusion body
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complex can be properly renatured and purified by
glutathione–agarose gel.
3.4. Purity and properties of purified recombinant
QPs1
About 86 mg of purified recombinant GST–QPs1
fusion protein, 78 mg from the cell extract and 8 mg
from inclusion body precipitates, is recovered from a
12 l cell culture. When this purified preparation is
  ..subjected to SDS-PAGE lane 3 of Fig. 2 A , three
major protein bands are observed: one with an appar-
ent molecular weight of 41 kDa which accounts for
65% of the total protein, one with a molecular weight
of about 68 kDa that accounts for 5% of the total
protein and one smear band with the molecular weight
span from 26.5 to 27 kDa that accounts for 30% of
the total protein. The 41 kDa protein is GST–QPs1
fusion protein, the 26.5–27 kDa smear band contains
incomplete GST–QPs1 fusion proteins, and the
68 kDa band is a contaminant protein. These assign-
ments are based on the observation that both 41 kDa
and 26.5–27 kDa proteins react with antibodies
  ..against QPs1 lane 3 of Fig. 2 B and produce GST
 . M s26 000 Da upon thrombin digestion see laner
 ..4 of Fig. 2 A . To date, we have been unable to
obtain an GST–QPs1 preparation free of incomplete
GST–QPs1 proteins, with a reasonable yield. How-
ever, the introduction of a 0.1 mM glutathione wash-
ing of the GST–QPs1 bound glutathione–agarose gel
prior to elution of GST–QPs1 with 5 mM glutathione
decreases the amount of incomplete GST–QPs1 pro-
teins in the final preparation.
QPs1 is progressively released from GST–QPs1
fusion protein by treatment with thrombin 0.5
.unitrmg protein at room temperature. The reaction
is complete after 30 min of incubation at room tem-
perature. Recombinant QPs1 released from GST be-
comes highly aggregated and is recovered as a pre-
cipitate. The aggregation of QPs1 in aqueous solution
is apparently due to the presence of hydrophobic
domains, the three transmembrane helices, in the
w xprotein 4 . Inclusion of 0.01% of dodecyl maltoside
during thrombin digestion does not affect thrombin
activity and permits recovery of QPs1 in a soluble
 .detergent dispersed form. When this thrombin di-
gested fusion protein is applied to a Superose-12
FPLC column equilibrated with 50 mM Tris–Cl, pH
7.8, containing 0.01% dodecyl maltoside, purified
recombinant QPs1 is recovered in the void volume,
indicating that purified QPs1, in 0.01% dodecylmal-
toside, is still highly aggregated, with apparent
molecular mass of over 1 million. The Superose-12
column chromatography separates uncleaved GST–
QPs1 fusion protein, released GST, and thrombin,
from QPs1. When the QPs1 containing fraction re-
covered from the Superose-12 column is subjected to
 .Fig. 2. Identity of recombinant QPs1. A SDS-PAGE of isolated recombinant QPs1. Lane 1, molecular weight standard; lane 2, bovine
heart mitochondrial succinate–ubiquinone reductase; lane 3, glutathione–agarose gel purified recombinant GST–QPs1; lane 4, thrombin
w xdigested recombinant GST–QPs1; and lane 5, purified recombinant QPs1. The high resolution SDS-PAGE gel of Schagger et al. 28 was¨
 .  .used. B The proteins on the gel of A were electrophoretically transferred to a nitrocellulose membrane, without staining, and reacted
with anti-QPs1 antibodies. Protein A horseradish peroxidase conjugate was used as the second antibody.
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SDS-PAGE, a single band, corresponding to the third
 .subunit QPs1 of purified succinate–ubiquinone re-
  ..ductase, is observed lane 5 of Fig. 2 A . However,
when this purified recombinant QPs1 is subjected to
partial N-terminal amino acid sequencing, two extra
residues, glycine and threonine, are observed. The
addition of these two extra residues is due to the
recombinant manipulation.
It should be noted that purified recombinant QPs1
obtained from soluble cell extracts, and from the
soluble fraction recovered from inclusion body pre-
cipitates, have the same purity and hydrodynamic
properties.
3.5. Reconstitution and properties of cytochrome b-
560 formed from GST–QPs1 fusion protein and heme
Although QPs1 is believed to be cytochrome b-560
w xwith bis-histidine ligands 19 , isolated recombinant
QPs1, obtained from cultures with or without
aminolevulinic acid, contains little cytochrome b-560
heme. Probably the lack of cytochrome b-560 heme
in recombinant QPs1 results from the inability of E.
coli DH5arpGEX-QPs1 cells to either incorporate
heme into apoprotein or to produce enough heme. In
other words, the expressed GST–QPs1 fusion protein
has the correct structure for heme ligation and cy-
tochrome b-560 can be formed if heme is available.
One way to test these possibilities is to reconstitute
cytochrome b-560 to recombinant QPs1 with heme.
Since recombinant GST–QPs1 is soluble, reconstitu-
tion of cytochrome b-560 was first attempted with
the fusion protein.
Fig. 3 shows generation of cytochrome b-560 from
GST–QPs1 fusion protein after addition of hemin
 .chloride. The maximum absorption peak Soret band
of the oxidized form of heme progressively shifts
from 398 nm to 411 nm, with increasing absorption
 .intensity, during the incubation data not shown . It
takes 2 h to complete the spectral red shift and to
reach maximum absorption. When the reaction was
complete, dithionite was added to reduce the sample
which now showed a symmetrical a-absorption at
559.5 nm, a broad b-absorption peak at 530 nm, and
Soret absorption at 425 nm. These absorption charac-
teristics are identical to those of cytochrome b-560 in
an isolated, reconstitutively active QPs preparation
Fig. 3. Restoration of cytochrome b-560 to isolated recombinant
GST–QPs1 fusion protein by heme. 3ml aliquots of hemin
 .chloride 6.18 mM in DMSO were added to 1 ml of purified
recombinant GST–QPs1 fusion protein, 3.1 mgrml, in 50 mM
Tris–Cl buffer, pH 8.0, containing 0.25 M sucrose. The mixtures
were incubated at room temperature and absorption spectra were
recorded from time to time during the incubation period. When
the oxidized Soret absorption peak no longer changed
 ., a small amount of dithionite was added and spectra
 .recorded - - - . The inserts are the difference spectra of the
dithionite-reduced vs. oxidized form at the a and b absorption
regions.
w x7 . Thus, cytochrome b-560 is restored to GST–QPs1
fusion protein by heme addition.
Since GST from Scistosoma japonicum in recom-
binant GST–QPs1 contains 6 histidines and is re-
w xported to have heme binding activity 36 , it is impor-
tant to establish that the bis-histidine ligands of re-
constituted cytochrome b-560 in GST–QPs1 are pro-
vided by the QPs1, and not by the GST moiety. This
is achieved by comparing the absorption spectra and
EPR characteristics of heme-ligated GST with those
of heme-ligated GST–QPs1, and by isolating recon-
stituted cytochrome b-560 in QPs1 from heme-ligated
GST–QPs1 after thrombin digestion. Recombinant
GST is produced in DH5arpGEX cells and purified
by glutathione–agarose gel. Since, after addition of
heme to purified recombinant GST, under conditions
identical with those for GST–QPs1, no cytochrome
 .b-560 spectra is produced data not shown , the
bis-histidine ligands of reconstituted cytochrome b-
560 are provided by the QPs1 moiety of the fusion
protein. The heme-ligated GST shows a very broad
a-absorption at 540 nm in the dithionite-reduced form.
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Fig. 4. Epr spectra of reconstituted cytochrome b-560, thrombin-
treated reconstituted cytochrome b-560, heme-added GST, and
free heme. 18 ml aliquots of hemin chloride, 8.0 mM, in DMSO
were added to 0.9 ml of 50 mM Tris–Cl buffer, pH 8.0, contain-
 .  .ing A GST–QPs1 fusion protein, 10 mgrml; C purified re-
 .combinant GST, 10 mgrml; D none. The mixtures were incu-
bated at room temperature, with stirring, for 2 h prior to EPR
 .  .measurement. Trace B was taken after treatment of A with
 .thrombin 0.01 unitrmg protein for 1 h at room temperature. The
EPR instrument settings were: modulation frequency, 100kHz;
modulation amplitude, 20 G; time constant, 0.5 s; microwave
frequency, 9.42 GHz; microwave power, 20 mW; scan rate,
200Grs; and temperature, 11 K.
Fig. 4 shows EPR characteristics of heme-ligated
GST–QPs1, heme-ligated GST, and free heme. Re-
constituted cytochrome b-560 in GST–QPs1 shows
 .an EPR peak at gs2.91 trace A of Fig. 4 , which
differs completely from the EPR characteristics of
heme-treated GST gs3.50 and gs3.86, trace C
. of Fig. 4 and of free heme a broad peak with
.gs3.80, trace D of Fig. 4 . When reconstituted
cytochrome b-560 in GST–QPs1 is treated with
thrombin, no change in EPR characteristics is ob-
 .served see trace B of Fig. 4 . These support the
results obtained from absorption spectra which indi-
cate that the bis-histidine ligands of cytochrome b-560
are in the QPs1 moiety. The gs2.91 EPR signal
observed for reconstituted cytochrome b-560 in re-
combinant QPs1 corresponds to one of the two EPR
 .signals gs2.91 and gs3.07 observed for cy-
tochrome b-560 in isolated QPs. This gs2.91 signal
of cytochrome b-560 in isolated QPs is not affected
by the addition of succinate dehydrogenase to QPs to
w xform succinate–ubiquinone reductase 7 .
To further confirm that QPs1 provides bis-histidine
ligands for cytochrome b-560 reconstituted with
GST–QPs1, the heme-ligated fusion protein was
treated with thrombin and subjected to a Superose-12
FPLC column chromatography to separate QPs1 from
GST. Each column eluate fraction was analyzed by
spectra, SDS-PAGE, and Western blotting. About
80% of the reconstituted cytochrome b-560 was re-
covered in fractions containing only QPs1. No cy-
tochrome b-560 was found in the GST-containing
fractions. Thus, QPs1 provides both histidine ligands
of cytochrome b-560. This is in contrast to the report
w xby Nakamura et al. 20 which says that one of the
bis-histidine ligands of cytochrome b-556 of E. coli
succinate–ubiquinone reductase is contributed by
SdhC and other by Sdh D. We are currently trying to
identify, by site-directed mutagenesis, which two his-
tidines in QPs1 are involved in heme ligation.
Reconstitution of cytochrome b-560 into GST–
QPs1 is heme concentration dependent. When GST–
QPs1 is incubated with various amounts of hemin
chloride, the peak height at 559.5 nm increases as the
 .amount of heme added is increased Fig. 5 . Maxi-
mum reconstitution is reached when the molar ratio
Fig. 5. Effect of heme concentration on the reconstitution of
cytochrome b-560 in recombinant GST–QPs1 fusion protein.
One ml aliquots of purified recombinant GST–QPs1 fusion pro-
tein, 0.7 mgrml, in 50 mM Tris–Cl, pH 8.0, were added to 3ml
of DMSO containing indicated concentrations of hemin chloride.
Mixtures were incubated at room temperature for 2 h and differ-
ence spectra between the oxidized and reduced forms of each
 .sample were measured before = and after thrombin digestion
 .‘ . The thrombin digestion was carried out with 0.01 unitrmg
protein at room temperature for 1 h.
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of heme to fusion protein used in the system is 0.6.
When the heme to protein ratio is higher than 0.6, the
sample shows an increased absorbance at 559.5 nm
compared to that reconstituted with a 0.6 molar ratio
of heme, but with a discernible broad shoulder at
 .around 580 nm data not shown . This increased
559.5 nm absorbance is diminished when the sample
 .is treated with thrombin see Fig. 5 , indicating that
excess heme cross ligated to a histidine residue in the
GST moiety to form a cytochrome b-560-like spec-
tra. No change in 559.5 nm absorbance is observed
with reconstituted cytochrome b-560, formed with
less than 0.6 molar ratio of heme, after thrombin
digestion. A millimolar coefficient for reconstituted
cytochrome b-560 is calculated to be 9.9 cmy1 for
A yA of the difference spectra of the559.5 nm 575 nm
dithionite-reduced minus the oxidized forms. This
value is about half that determined for cytochrome
b-560 in isolated QPs.
The less than unit reconstitution can be explained
 .by 1 the presence of some incomplete GST–QPs1
 .proteins in the isolated fusion protein preparation; 2
partial availability of one of the histidine ligands in
the QPs1 moiety resulting from the aggregation of
isolated fusion protein in aqueous solution. When this
partially available histidine residue is completely lig-
ated by heme, excess heme is ligated to a histidine
residue in the GST moiety to form a cytochrome
b-560-like spectra which is diminished by thrombin
 .digestion; 3 the two histidine ligands are from
different QPs1 molecules. In this case, only one
histidine residue of each QPs1 is involved. Results
described in the next section seem to support the first
possibility.
The incomplete GST–QPs1 C-terminal truncated
.QPs1 proteins account for about 30% of the total
protein in the isolated fusion protein preparation see
 ..line 3 of Fig. 2 A . These C-terminal truncated QPs1
proteins are probably missing one or both of the two
 .highly conserved histidine residues H42 and H98 in
QPs1 since the apparent molecular masses of these
proteins are 500–1000 Da. If the bis-histidine ligands
of reconstituted cytochrome b-560 in GST–QPs1 are
provided by the intact QPs1 moiety, 1 mol of heme
ligated into 1 mol of intact QPs1–GST in the prepara-
tion will give maximum reconstitution with a 0.6
molar ratio of heme added. This idea is supported by
the recovery of reconstituted cytochrome b-560 in
QPs1, with a heme to protein ratio of 0.9, by a
Sepharose-12 column chromatography, from throm-
bin treated, heme-ligated GST–QPs1 having a heme
to protein ratio of 0.57. Furthermore, the amount of
cytochrome b-560 restoration into GST–QPs1 corre-
lates with the amount of intact QPs1 present in the
fusion protein preparation. Addition of heme to a
GST–QPs1 preparation enriched with incomplete
 .QPs1–GST proteins to about 80% , gives maximum
 .reconstitution 2 nmolrmg when the heme to protein
ratio in the system is 0.18. The incomplete GST–QPs1
enriched preparation is obtained in a 0.1 mM glu-
tathione washing of GST–QPs1 adsorbed on glu-
tathione–agarose gel during purification.
To date we have been unable to reconstitute re-
combinant QPs1 with succinate dehydrogenase to
form succinate-Q reductase. We observe no change in
the absorption spectra, EPR characteristics, and car-
bon monoxide reactivity of reconstituted cytochrome
b-560 in GST–QPs1 or in QPs1 upon addition of
succinate dehydrogenase. This indicates that no spe-
cific interaction occurs between succinate dehydroge-
nase and recombinant QPs1. The failure of reconsti-
tuted cytochrome b-560 in GST–QPs1 or in QPs1 to
interact with succinate dehydrogenase to form succi-
nate–ubiquinone reductase may be due to a require-
ment of QPs2 or QPs3 for this interaction. Reconsti-
tution studies including all the recombinant QPs sub-
units are currently in progress in our laboratory.
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